MASTER PURCHASE AND SALE AGREEMENT by and among BIOTEST PHARMACEUTICALS CORPORATION, ADMA BIOMANUFACTURING, LLC, ADMA BIOLOGICS, INC., and solely for the purposes of Sections 6.7, 8.13, 8.14 and ARTICLE XII, BIOTEST AG and BIOTEST US CORPORATION Dated...Stockholders Agreement • January 23rd, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 23rd, 2017 Company Industry JurisdictionTHIS MASTER PURCHASE AND SALE AGREEMENT (this “Agreement”), dated as of January 21, 2017 (the “Execution Date”), is entered into by and among BIOTEST PHARMACEUTICALS CORPORATION, a Delaware corporation (“Seller”), ADMA BIOMANUFACTURING, LLC, a Delaware limited liability company (“Buyer”), ADMA BIOLOGICS, INC., a Delaware corporation (“ADMA”) and, solely for the purposes of Sections, 6.7, 8.13, 8.14, and ARTICLE XII, BIOTEST AG, a company organized under the laws of Germany (“Biotest”), and BIOTEST US CORPORATION, a Delaware corporation (together with Biotest, the “Biotest Guarantors”). Each of Seller, Buyer, ADMA and the Biotest Guarantors are sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.”